See more : Nubia Brand International Corp. (NUBI) Income Statement Analysis – Financial Results
Complete financial analysis of Par Drugs and Chemicals Limited (PAR.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Par Drugs and Chemicals Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- MTN Group Limited (MTNOF) Income Statement Analysis – Financial Results
- Silicon Craft Technology Public Company Limited (SICT.BK) Income Statement Analysis – Financial Results
- Brookfield DTLA Fund Office Trust Investor Inc. (DTLA-P) Income Statement Analysis – Financial Results
- Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) Income Statement Analysis – Financial Results
- HELLA GmbH & Co. KGaA (HLE.DE) Income Statement Analysis – Financial Results
Par Drugs and Chemicals Limited (PAR.NS)
About Par Drugs and Chemicals Limited
Par Drugs and Chemicals Limited develops, produces, and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, and amorphous and blended products. The company also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 956.40M | 950.95M | 742.00M | 598.80M | 550.97M | 455.97M | 420.34M | 467.19M | 332.64M |
| Cost of Revenue | 346.53M | 664.05M | 498.64M | 374.37M | 396.27M | 324.89M | 295.26M | 351.15M | 128.61M |
| Gross Profit | 609.88M | 286.90M | 243.36M | 224.43M | 154.70M | 131.08M | 125.08M | 116.04M | 204.03M |
| Gross Profit Ratio | 63.77% | 30.17% | 32.80% | 37.48% | 28.08% | 28.75% | 29.76% | 24.84% | 61.34% |
| Research & Development | 0.00 | 1.01M | 147.42K | 988.00K | 666.39K | 543.21K | 225.37K | 0.00 | 0.00 |
| General & Administrative | 16.40M | 12.41M | 14.55M | 7.91M | 12.61M | 9.86M | 4.42M | 4.63M | 0.00 |
| Selling & Marketing | 53.82M | 47.64M | 32.57M | 21.68M | 11.84M | 8.14M | 6.88M | 10.52M | 0.00 |
| SG&A | 54.99M | 60.05M | 47.12M | 29.59M | 24.45M | 18.00M | 11.30M | 15.15M | 22.09M |
| Other Expenses | 0.00 | 2.38M | 1.84M | 508.02K | 66.86M | 63.31M | 65.43M | 45.11M | 0.00 |
| Operating Expenses | 58.29M | 141.38M | 116.81M | 92.81M | 90.18M | 79.39M | 76.62M | 59.62M | 159.33M |
| Cost & Expenses | 404.82M | 805.43M | 615.45M | 467.18M | 486.45M | 404.28M | 371.88M | 410.78M | 287.94M |
| Interest Income | 2.32M | 719.00K | 1.84M | 1.32M | 604.83K | 887.00K | 400.00K | 347.00K | 34.63M |
| Interest Expense | 1.07M | 24.00K | 3.77M | 6.03M | 7.54M | 18.12M | 19.91M | 24.42M | 0.00 |
| Depreciation & Amortization | 34.36M | 32.33M | 32.81M | 28.19M | 27.62M | 30.37M | 31.36M | 28.20M | 26.50M |
| EBITDA | 229.53M | 182.07M | 162.55M | 181.88M | 94.49M | 82.14M | 80.21M | 84.61M | 71.88M |
| EBITDA Ratio | 24.00% | 19.08% | 22.05% | 26.98% | 17.19% | 17.83% | 18.27% | 18.06% | 21.61% |
| Operating Income | 551.59M | 149.74M | 129.74M | 131.94M | 66.87M | 51.69M | 48.46M | 56.41M | 45.38M |
| Operating Income Ratio | 57.67% | 15.75% | 17.48% | 22.03% | 12.14% | 11.34% | 11.53% | 12.07% | 13.64% |
| Total Other Income/Expenses | -356.42M | -346.21M | -288.31M | 15.64M | -4.60M | -18.86M | -22.93M | -24.58M | -35.31M |
| Income Before Tax | 195.17M | 150.79M | 127.03M | 147.26M | 59.92M | 32.84M | 25.53M | 31.83M | 10.07M |
| Income Before Tax Ratio | 20.41% | 15.86% | 17.12% | 24.59% | 10.88% | 7.20% | 6.07% | 6.81% | 3.03% |
| Income Tax Expense | 50.16M | 37.45M | 34.88M | 31.15M | 12.27M | 8.65M | 10.58M | 13.36M | 5.85M |
| Net Income | 145.01M | 113.34M | 92.13M | 116.11M | 47.65M | 24.19M | 14.95M | 18.48M | 4.22M |
| Net Income Ratio | 15.16% | 11.92% | 12.42% | 19.39% | 8.65% | 5.30% | 3.56% | 3.96% | 1.27% |
| EPS | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 1.97 | 1.22 | 1.50 | 0.78 |
| EPS Diluted | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 1.97 | 1.22 | 1.50 | 0.78 |
| Weighted Avg Shares Out | 12.31M | 12.30M | 12.30M | 6.15M | 6.15M | 12.30M | 12.30M | 12.30M | 5.41M |
| Weighted Avg Shares Out (Dil) | 12.30M | 12.30M | 12.30M | 6.15M | 6.15M | 12.30M | 12.30M | 12.30M | 5.40M |
Source: https://incomestatements.info
Category: Stock Reports